Gene silencing by RNA interference: a review
Suresh Malakondaiah, Angeline Julius, Divyadharshini Ponnambalam, Summana Sree Gunthoti, Joshitha Ashok, Poorni Santhana Krishana, Jeyanthi Rebecca
Genome Instability & Disease ›› 2024, Vol. 5 ›› Issue (5) : 225-241.
Gene silencing by RNA interference: a review
RNA interference (RNAi)-based gene silencing has emerged as a potent method for regulating gene expression, with applications spanning biology, medicine, and biotechnology. RNAi exploits natural cellular machinery to selectively suppress target gene expression through the targeted degradation of mRNA based on its specific sequence. MicroRNAs (miRNAs) and small interfering RNAs (siRNAs) are two examples of tiny RNA molecules that are introduced during this process; they direct the silencing complex induced by RNA (RISC) in response to complementary mRNA and repress its translation. Several biological functions, including cellular homeostasis maintenance and developmental regulation against viral infections and transposable elements, depend heavily on RNAi-mediated gene silencing. In research, RNAi has revolutionized functional genomics by enabling high-throughput analysis of gene functions and regulatory networks. Moreover, RNAi-based screening approaches have facilitated the discovery of novel drug targets and therapeutic agents. In medicine, RNAi shows potential for addressing genetic disorders, viral infections, cancer, and other diseases by providing a means for precise and targeted intervention. Nevertheless, issues with delivery, specificity, immunogenicity, and safety impede the clinical translation of RNAi-based treatments. RNAi has shown great promise in biotechnology and agriculture for bioproduction, crop improvement, and pest management. Despite these challenges, the rapid advancement of RNAi research and technology holds immense potential to further our understanding of gene regulation and revolutionize therapeutic interventions. An overview of the relevance and uses of RNAi in gene silencing is given in this review, emphasizing the role it will play in directing future biological and medical research.
|
Ashraf, S., Ghouri, M. Z., Javed, M. A., Zafar, H., Ali, H., Qari, S. H., & Ahmad, A. (2022). Rna Editing with Crispr/Cas13. The CRISPR/Cas Tool Kit for Genome Editing, 219–254.
|
|
|
|
|
|
|
Bonfante, P., Nuti, M., & Stocchi, V. (2012). Biotechnology of Ectomycorrhizae: Molecular approaches. Springer Science & Business Media.
|
Chardon, F. (2023). CRISPR-Based Functional Genomics to Study Gene Regulatory Architecture and consequences of genetic variation. University of Washington.
|
|
Choudry, M. W., Nawaz, P., Jahan, N., Riaz, R., Ahmad, B., Raza, M. H., Fayaz, Z., Malik, K., & Afzal, S. (2024). RNA based gene silencing modalities to control insect and fungal plant pests–challenges and future prospects. Physiological and Molecular Plant Pathology, 102241.
|
|
|
|
Cummings, J. (2019). The role of biomarkers in Alzheimer’s disease drug development. Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders, 29–61.
|
|
|
|
|
|
Gao, J., & Li, F. (2024). Heterochromatin repeat organization at an individual level: Rex1BD and the 14-3‐3 protein coordinate to shape the epigenetic landscape within heterochromatin repeats. Bioessays, 2400030.
|
|
|
|
|
|
|
|
Jones, H. D. (2021). Gene silencing or gene editing: The pros and cons. RNAi for plant improvement and protection (pp. 47–53). CABI Wallingford UK.
|
|
|
|
Koh, H. B., Kim, H. J., Kang, S. W., & Yoo, T. H. (2023). Exosome-based drug delivery: translation from bench to clinic. Pharmaceutics, 15(8), 2042.
|
|
|
|
Liu, S., Geng, S., Li, A., Mao, Y., & Mao, L. (2021). RNAi technology for plant protection and its application in wheat. Abiotech, 1–10.
|
Loscalzo, J., & Handy, D. E. (2014). Epigenetic modifications: basic mechanisms and role in cardiovascular disease (2013 Grover Conference series). Pulmonary Circulation, 4(2), 169–174.
|
Lu, A. T., Fei, Z., Haghani, A., Robeck, T. R., Zoller, J. A., Li, C. Z., Lowe, R., Yan, Q., Zhang, J., & Vu, H. (2021). Universal DNA methylation age across mammalian tissues. BioRxiv, 2001–2021.
|
|
|
|
|
|
|
|
Pandey, P., Mysore, K. S., & Senthil-Kumar, M. (2022). Recent advances in plant gene silencing methods. Plant Gene Silencing: Methods and Protocols, 1–22.
|
Pardridge, W. M. (2022). Advanced blood–brain barrier drug delivery. Pharmaceutics (Vol. 15, p. 93). MDPI. 1.
|
|
|
Pun, F. W., Ozerov, I. V., & Zhavoronkov, A. (2023). AI-powered therapeutic target discovery. Trends in Pharmacological Sciences.
|
|
|
|
|
|
Saakre, M., Jaiswal, S., Rathinam, M., Raman, K. V., Tilgam, J., Paul, K., Sreevathsa, R., & Pattanayak, D. (2023). Host-delivered RNA interference for durable pest resistance in plants: Advanced methods, challenges, and applications. Molecular Biotechnology, 1–20.
|
Sarkar, A., Singh, P., & Varkey, M. (2024). Healthcare Artificial Intelligence in India and ethical aspects. AI, consciousness and the New Humanism: Fundamental reflections on minds and machines (pp. 107–150). Springer.
|
Sehki, H., Yu, A., Elmayan, T., & Vaucheret, H. (2023). TYMV and TRV infect Arabidopsis thaliana by expressing weak suppressors of RNA silencing and inducing host RNASE THREE LIKE1. PLoS Pathogens, 19(1), e1010482.
|
Semple, S. L., Au, S. K., Jacob, R. A., Mossman, K. L., & DeWitte-Orr, S. J. (2022). Discovery and use of long dsRNA mediated RNA interference to stimulate antiviral protection in interferon-competent mammalian cells. Frontiers in Immunology, 13, 859749.
|
|
|
Skotte, N. H., Southwell, A. L., Østergaard, M. E., Carroll, J. B., Warby, S. C., Doty, C. N., Petoukhov, E., Vaid, K., Kordasiewicz, H., & Watt, A. T. (2014). Allele-specific suppression of mutant huntingtin using antisense oligonucleotides: Providing a therapeutic option for all Huntington disease patients. PloS One, 9(9), e107434.
|
|
|
|
|
|
Torri, A., Jaeger, J., Pradeu, T., & Saleh, M. C. (2022). The origin of RNA interference: Adaptive or neutral evolution? PLoS Biology, 20(6), e3001715.
|
Trasser, M., Bohl-Viallefond, G., Barragan-Borrero, V., Diezma-Navas, L., Loncsek, L., Nordborg, M., & Mari-Ordonez, A. (2024). PTGS is dispensable for the initiation of epigenetic silencing of an active transposon in Arabidopsis. BioRxiv, 2005–2024.
|
|
|
|
|
|
Zabala-Pardo, D., Gaines, T., Lamego, F. P., & Avila, L. A. (2022). RNAi as a tool for weed management: Challenges and opportunities. Advances in Weed Science, 40(spe 1), e020220096.
|
Zapletal, D., Kubicek, K., Svoboda, P., & Stefl, R. (2023). Dicer structure and function: Conserved and evolving features. EMBO Reports, 24(7), e57215.
|
Zhan, L., Zhang, Y., Wang, Y., Wang, A., Cheng, C., Zhao, J., Zhang, W., Lia, P., & Chen, J. (2024). A genome-scale deep learning model to predict gene expression changes of genetic perturbations from multiplex biological networks. ArXiv Preprint ArXiv:2403.02724.
|
|
|
|
|
|
/
〈 |
|
〉 |